Navigation Links
Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM)
Date:11/30/2009

AMSTERDAM, November 30 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma announces today that the first patients have been enrolled in its multinational registration clinical trial with ATIR(TM). The study is designed to show reduction in transplant related mortality (TRM) after one year following an allogeneic stem cell transplantation with a mismatched (haplo-identical) donor in blood cancer patients eligible for an allogeneic stem cell transplantation but without having a matched donor available.

The study is currently open for enrollment in centers in Europe and Canada and is designed to serve as a registration trial for European approval.

"We are very pleased to initiate the registration study following excellent clinical results from the phase I/II study with ATIR(TM)." says Dr. Manja Bouman, CEO of Kiadis Pharma. "ATIR(TM) has shown a low TRM at one year post transplantation and a high overall survival in a patient population with no standard treatment options left. As an orphan product addressing a high unmet need, we aim to take advantage of a fast development path for ATIR(TM)."

"As the pioneer of ATIR(TM) I am very excited about this next major development milestone, a multinational registration study" says Dr. Denis Claude Roy of the University of Montreal. "I am a strong believer that ATIR(TM) will open up a whole new treatment field for a very large patient group which currently has no treatment options left."

About ATIR(TM)

ATIR(TM), a donor lymphocyte preparation depleted of alloreactive T-cells, is under development to reduce transplant related mortality (TRM) following an allogeneic hematopoietic stem cell transplantation (HSCT). ATIR(TM) is designed to provide early immune reconstitution to fight infections and remaining tumor cells (by eliminating the use of prophylactic immune suppressants) while preventing acute severe (Grade III
'/>"/>

SOURCE Kiadis Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Kiadis Pharma Reports Successful End of Phase II Meeting With FDA for Reviroc
2. Kiadis Pharma Receives Orphan Drug Designation for Rhitol(TM) From the FDA
3. EMEA Grants Kiadis Pharma Lead Product ATIR(TM) Orphan Drug Designation
4. Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)
5. Kiadis Pharma Appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer
6. Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations
7. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
8. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
11. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 2015 Health eCareers, the only online single-source ... this week announced the launch of ENA Job ... The ENA Job Center provides a powerful venue ... find job openings and for employers to reach the ... in the field. Job seekers now ...
(Date:3/6/2015)... NC (PRWEB) March 06, 2015 Strategic ... formally announced its new name, Able&Co. , The agency ... experienced impressive growth since its inception, continuing to expand ... seasoned and multi-disciplined agency with a core focus on ... future, we want our name and visual identity to ...
(Date:3/6/2015)... InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), ... will release its full financial results for the fourth quarter ... th after market close, followed by a conference call ... business outlook. Participants should call (888) 243-4451 ( ... request the InspireMD call. A live webcast of the call ...
(Date:3/6/2015)... DALLAS , March 6, 2015 ... Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, ... Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global ... Repair Market is expected to reach $14.7 Billion in ... CAGR of 7.5% from 2014 to 2019. ...
Breaking Biology Technology:Health eCareers Announces Online Career Center for the Emergency Nurses Association 2Health eCareers Announces Online Career Center for the Emergency Nurses Association 3Red House Group Reveals New Identity as Able&Co. 2InspireMD to Report Financial Results for the Fourth Quarter and Year Ended December 31, 2014 on Thursday, March 12th 2Soft Tissue Repair Market worth $14.7 Billion in 2019 2Soft Tissue Repair Market worth $14.7 Billion in 2019 3Soft Tissue Repair Market worth $14.7 Billion in 2019 4
... 4 Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: ... quarterly royalty payment of approximately $2.1 million ... Memantine for the treatment of,moderate-to-severe Alzheimer,s disease. ... quarterly royalty payments on certain,sales of Memantine ...
... Anacor Pharmaceuticals,announced today that it has appointed Kurt Jarnagin, ... are pleased to welcome Kurt to the company," said ... Pharmaceuticals. "Kurt,is a noted expert in the field of ... enrich our team as we continue to,expand our pipeline ...
... SEATTLE, Aug. 2 "The federal government,s ability to,more exactly ... States,annually is a great statistical tool -- but that is ... They remind us that HIV/AIDS continues,to be a real public ... nations around the globe. Despite recent setbacks in developing,an effective ...
Cached Biology Technology:Anacor Pharmaceuticals Appoints Dr. Kurt Jarnagin Vice President of Biological Research 2
(Date:3/5/2015)... , March 5, 2015 In ... percent of companies already using these solutions and 42 percent ... Of the latter, approximately 25 percent of the companies will ... While the majority of companies in the region are ... that the hybrid model will command significant attention in the ...
(Date:3/4/2015)... 2015 Research and Markets ( ... "Global Biometrics Market Forecast and Opportunities, 2020" ... market for biometric authentication systems is projected to ... 2020 The driving forces for this ... government projects and constant development in technology. In ...
(Date:3/3/2015)... , March 3, 2015 Cryoport, ... of advanced cryogenic logistics solutions for the ... stem cells, cell lines, clinical research organizations, ... today announced the expansion of its relationship ... ("Fred Hutch") Clinical Research Division with ...
Breaking Biology News(10 mins):Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
... have 43 percent increased odds of having moderate ... birth compared to mothers of single-born children, according ... of Public Health. Researchers examined the relationship between ... that multiple births increased the odds of maternal ...
... Bacteria are single cell organisms with no nervous system ... as part of a complex community called a biofilm ... producing the "glue" that forms the biofilm)? ... Society for General Microbiology,s meeting in Harrogate, (Monday 30 ...
... Understanding the tens of thousands of proteins that compose the ... century, and research efforts to date have already enabled major ... potential avenues have been blocked by lack of information about ... bulk of these so far enigmatic proteins may now be ...
Cached Biology News:Mothers of multiple births at increased odds of postpartum depression 2New high-throughput screening technique makes probing puzzling proteins possible 2New high-throughput screening technique makes probing puzzling proteins possible 3New high-throughput screening technique makes probing puzzling proteins possible 4New high-throughput screening technique makes probing puzzling proteins possible 5
... Gel loading buffer is especially formulated ... of nucleic acids. The gel loading solution ... sucrose to add density and facilitate sample ... nucleases that require divalent cations and SDS ...
... systems. , Integrated Instrument Control , ... EZChrom Elite can be configured with a ... provides a completely integrated system to control instrument's operation, collect andstore ... ...
Rabbit anti Xanthine Oxidase Xanthine Oxidase, Bovine Buttermilk...
... SilverSNAP Stain for Mass Spectrometry Applications ... spectrometry (MS) has emerged as a powerful ... of 2-D gels is now an important ... that leads ultimately to identification of specific ...
Biology Products: